Latest price updates for imported Mirikizumab in 2025

Mirikizumab is an injectable drug for adults with ulcerative colitis that can effectively relieve symptoms caused by swelling and ulcers in the lining of the colon and rectum. As a monoclonal antibody drug, militizumab inhibits the activity of specific cells, thereby reducing the inflammatory response and improving the patient's quality of life.

This medication is available as a solution that is usually given intravenously in a health care setting by a doctor or nurse over a period of at least30 minutes. Militizumab is also available in a prefilled pen for subcutaneous injection at home. The standard treatment regimen includes the first three intravenous injections at weeks 0, 4, and 8, followed by maintenance subcutaneous injections every 4 weeks.

When using militizumab, patients must strictly follow the instructions on the prescription label to ensure safe use and avoid over- or under-dosing. If you choose to self-inject, be sure to read the instructions for use carefully and consult your doctor or pharmacist if you have questions. At the same time, patients should maintain regular communication with their medical team to ensure the safety and effectiveness of the treatment process.

Currently, Militizumab, as the original drug, has not yet been officially launched in the domestic market, and its specific price has not yet been determined. According to the situation in overseas markets, the common specification of this drug is 300mg/15mL per tube, and the price per box may exceed RMB 10,000 (the specific price is affected by exchange rate fluctuations). It should be noted that there are currently no relevant generic drugs available for purchase in overseas markets, which makes the overall treatment cost of militizumab relatively high. For more information on overseas drug prices and related information, please consult Yaode Medical Consultant.

Reference materials:https://medlineplus.gov/druginfo/meds/a623061.html